139 related articles for article (PubMed ID: 38027223)
1. Small breast epithelial mucin as a useful prognostic marker for breast cancer patients.
Hao H; Yang L; Wang B; Sang Y; Liu X
Open Life Sci; 2023; 18(1):20220784. PubMed ID: 38027223
[TBL] [Abstract][Full Text] [Related]
2. Small breast epithelial mucin tumor tissue expression is associated with increased risk of recurrence and death in triple-negative breast cancer patients.
Liu L; Liu Z; Qu S; Zheng Z; Liu Y; Xie X; Song F
Diagn Pathol; 2013 May; 8():71. PubMed ID: 23635316
[TBL] [Abstract][Full Text] [Related]
3. Expression of TRPC1 and SBEM protein in breast cancer tissue and its relationship with clinicopathological features and prognosis of patients.
Zhang Y; Lun X; Guo W
Oncol Lett; 2020 Dec; 20(6):392. PubMed ID: 33193852
[TBL] [Abstract][Full Text] [Related]
4. Small breast epithelial mucin (SBEM) has the potential to be a marker for predicting hematogenous micrometastasis and response to neoadjuvant chemotherapy in breast cancer.
Liu ZZ; Xie XD; Qu SX; Zheng ZD; Wang YK
Clin Exp Metastasis; 2010 Apr; 27(4):251-9. PubMed ID: 20364301
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of survivin and EGFR protein expression in triple-negative breast cancer (TNBC) patients.
Zhang M; Zhang X; Zhao S; Wang Y; Di W; Zhao G; Yang M; Zhang Q
Target Oncol; 2014 Dec; 9(4):349-57. PubMed ID: 24233638
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic accuracy of small breast epithelial mucin mRNA as a marker for bone marrow micrometastasis in breast cancer: a pilot study.
Valladares-Ayerbes M; Iglesias-Díaz P; Díaz-Prado S; Ayude D; Medina V; Haz M; Reboredo M; Antolín S; Calvo L; Antón-Aparicio LM
J Cancer Res Clin Oncol; 2009 Sep; 135(9):1185-95. PubMed ID: 19221791
[TBL] [Abstract][Full Text] [Related]
7. Identification of a novel breast- and salivary gland-specific, mucin-like gene strongly expressed in normal and tumor human mammary epithelium.
Miksicek RJ; Myal Y; Watson PH; Walker C; Murphy LC; Leygue E
Cancer Res; 2002 May; 62(10):2736-40. PubMed ID: 12019145
[TBL] [Abstract][Full Text] [Related]
8. [Expression of small breast epithelial mucin mRNA in peripheral blood of breast cancer patients and its clinical significance].
Yang HW; Cao J; Yang NW; Liu JL; Zhang CM; Chen JS; Hong JS; Jiang Y; Su JJ
Ai Zheng; 2005 Jul; 24(7):842-5. PubMed ID: 16004812
[TBL] [Abstract][Full Text] [Related]
9. Stratification of Prognosis of Triple-Negative Breast Cancer Patients Using Combinatorial Biomarkers.
Yue Y; Astvatsaturyan K; Cui X; Zhang X; Fraass B; Bose S
PLoS One; 2016; 11(3):e0149661. PubMed ID: 26930401
[TBL] [Abstract][Full Text] [Related]
10. Expression of small breast epithelial mucin (SBEM) protein in tissue microarrays (TMAs) of primary invasive breast cancers.
Skliris GP; Hubé F; Gheorghiu I; Mutawe MM; Penner C; Watson PH; Murphy LC; Leygue E; Myal Y
Histopathology; 2008 Feb; 52(3):355-69. PubMed ID: 18269587
[TBL] [Abstract][Full Text] [Related]
11. Combination of PD-L1 expression and NLR as prognostic marker in patients with surgically resected non-small cell lung cancer.
Wang X; Cao L; Li S; Wang F; Huang D; Jiang R
J Cancer; 2019; 10(26):6703-6710. PubMed ID: 31777599
[No Abstract] [Full Text] [Related]
12. Prognostic Nutritional Index (PNI) in Patients With Breast Cancer Treated With Neoadjuvant Chemotherapy as a Useful Prognostic Indicator.
Chen L; Bai P; Kong X; Huang S; Wang Z; Wang X; Fang Y; Wang J
Front Cell Dev Biol; 2021; 9():656741. PubMed ID: 33859986
[TBL] [Abstract][Full Text] [Related]
13. Mutant p53 and Twist1 Co-Expression Predicts Poor Prognosis and Is an Independent Prognostic Factor in Breast Cancer.
Zhang YQ; Zhang F; Zeng YZ; Chen M; Huang WH; Wu JD; Chen WL; Gao WL; Bai JW; Yang RQ; Zeng HC; Wei XL; Zhang GJ
Front Oncol; 2021; 11():628814. PubMed ID: 34249678
[TBL] [Abstract][Full Text] [Related]
14. Prognostic influence of pre-operative C-reactive protein in node-negative breast cancer patients.
Sicking I; Edlund K; Wesbuer E; Weyer V; Battista MJ; Lebrecht A; Solbach C; Grinberg M; Lotz J; Hoffmann G; Rahnenführer J; Hengstler JG; Schmidt M
PLoS One; 2014; 9(10):e111306. PubMed ID: 25340395
[TBL] [Abstract][Full Text] [Related]
15. [Clinicopathological features and prognosis of hormone receptor-positive/human epidermal growth factor receptor 2-negative breast cancer].
Wang Y; Zhang S; Zhang H; Liang L; Xu L; Cheng YJ; Duan XN; Liu YH; Li T
Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Oct; 54(5):853-862. PubMed ID: 36241228
[TBL] [Abstract][Full Text] [Related]
16. TIF1γ interferes with TGFβ1/SMAD4 signaling to promote poor outcome in operable breast cancer patients.
Kassem L; Deygas M; Fattet L; Lopez J; Goulvent T; Lavergne E; Chabaud S; Carrabin N; Chopin N; Bachelot T; Gillet G; Treilleux I; Rimokh R
BMC Cancer; 2015 Jun; 15():453. PubMed ID: 26040677
[TBL] [Abstract][Full Text] [Related]
17. Prognostic influence of cyclooxygenase-2 protein and mRNA expression in node-negative breast cancer patients.
Sicking I; Rommens K; Battista MJ; Böhm D; Gebhard S; Lebrecht A; Cotarelo C; Hoffmann G; Hengstler JG; Schmidt M
BMC Cancer; 2014 Dec; 14():952. PubMed ID: 25511800
[TBL] [Abstract][Full Text] [Related]
18. In silico and in vitro analysis of small breast epithelial mucin as a marker for bone marrow micrometastasis in breast cancer.
Ayerbes MV; Díaz-Prado S; Ayude D; Campelo RG; Iglesias P; Haz M; Medina V; Gallegos I; Quindós M; Aparicio LA
Adv Exp Med Biol; 2008; 617():331-9. PubMed ID: 18497056
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of extranodal extension in sentinel lymph node positive breast cancer.
Yang X; Ma X; Yang W; Shui R
Sci Rep; 2020 Sep; 10(1):14684. PubMed ID: 32895434
[TBL] [Abstract][Full Text] [Related]
20. [Lack of progesterone receptor expression predicts poor prognosis in patients with operable ER-positive invasive breast cancer].
Ma RM; Chen CZ; Lin CQ; Zhang W; Guo GL
Zhonghua Zhong Liu Za Zhi; 2016 Sep; 38(9):687-92. PubMed ID: 27647402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]